J&J Wins 1st Trial Victory In Levaquin MDL
A Minnesota federal jury on Friday handed Johnson & Johnson its first trial victory in a multidistrict litigation that claims the antibiotic Levaquin causes serious tendon injuries, saying the pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article